Copper Cu-64 Dotatate Patent Expiration

Copper Cu-64 Dotatate is Used for localizing somatostatin receptor positive neuroendocrine tumors in adult patients. It was first introduced by Radiomedix Inc in its drug Detectnet on Sep 3, 2020.


Copper Cu-64 Dotatate Patents

Given below is the list of patents protecting Copper Cu-64 Dotatate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Detectnet US10159759 Pet tracer for imaging of neuroendocrine tumors Aug 23, 2032 Radiomedix
Detectnet US10383961 PET tracer for imaging of neuroendocrine tumors Aug 23, 2032 Radiomedix
Detectnet US11160888 PET tracer for imaging of neuroendocrine tumors Aug 23, 2032 Radiomedix


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳